Loading...
Improve patient care and your bottom line with comprehensive 340B pharmacy solutions
Our solutions help you offer your patients increased access to the medications they need, when and where they need them, which improves both quality of care and your financials.
Implementing a 340B pharmacy solution improves patient access to and utilization of 340B drugs by offering fulfillment at the Point of Care, and at the same time generates additional revenue streams for your facility.
Not only does it ensure your patients get access to the medications they need (thus improving patient compliance rates), but it also improves your overall quality of care and bottom line. It's particularly powerful when you also add new specialties such as Infectious Disease, Geriatric and Pulmonary.
Improve quality of care
Generate new revenue streams
Increase patient compliance
Reduce your overhead costs
Maintain HRSA compliance
We are pioneers in delivering 340B contract pharmacy services and specialized distribution programs for FQHCs.
Our management team and 340B specialists have long-term experience working for and with FQHCs – we understand your unique operational environment.
Our policies, procedures and platforms ensure compliance with 340B program requirements, reducing your risk and liability.
Comprehensive services designed to maximize your 340B program benefits
We evaluate your existing operation and patient mix to understand your 340B goals (e.g., drug discounts, revenues, service expansion). We work with you on a comprehensive plan to achieve those goals, analyzing services, encounters by payer mix, pharmacy arrangements, and available resources.
Outsourcing the management of an existing in-house pharmacy can reduce overhead, improve efficiency and generate additional revenue. Our experienced team works directly with pharmacy staff to deliver maximum capture rates, improve performance, and expand services.
We implement policies and procedures ensuring 340B program compliance. Our adjudication platform controls diversion risk by ensuring 340B drugs are only available to eligible patients. Stay updated via customized reporting tailored to your needs.
We help you choose the best combination of pharmacy options to meet your facility and patient requirements. We work closely with 340B administration companies and PBMs to ensure seamless implementation and consolidated reporting.
Where in-house pharmacy is not feasible, we leverage partner recapture programs to achieve maximum prescription revenues. Our partners offer real-time comprehensive integrated solutions that reduce regulatory compliance challenges.
We analyze your prescription patterns to create facility and site-specific formulary and pricing, offering maximum benefit to 340B eligible patients. We work directly with providers to develop seasonal formularies and Low Cost Generic programs.
HRSA is now performing 340B compliance audits and covered entities may lose their 340B status if they are not compliant with the overall stewardship of the program for which it was intended.
ACE can perform an independent third-party 340B compliance audit. The ACE audit would be performed on-site and remotely by a qualified and certified ACE audit team including pharmacists, analysts, and specialists in pharmacy benefits.
The evaluation report would prepare a covered entity for an actual HRSA audit and indicate areas to be addressed which may compromise the covered entities' participation in the 340B program.
HRSA remains committed to the integrity of the 340B program, including preventing the diversion of covered drugs to non-qualified patients and preventing drugs from being subject to duplicate discounts. The following provisions must be addressed:
Ship to, bill to procedure
Patient eligibility verification
Prescriber eligibility verification
Comprehensive pharmacy services
Tracking system
Arrangement to prevent duplicate discounts
Audits
Certification of contract pharmacy compliance
Response in the event of diversion or duplicate discounts
Re-certification process for covered entities
